[Section Editor’s Note: The following article is republished from The Final Call Vol. 42 No. 18.]
Ivermectin first exploded onto the scene as a potential therapeutic for COVID after researchers at Monash University in Australia published in April of 2020 that SARS-CoV-2 essentially disappeared from cell culture within 48 hours of being exposed to Ivermectin. Pulmonary specialist and critical care physician Dr. Pierre Kory, in his December 2022 series titled “The Timeline of Major Battles In the Global War on Ivermectin,”
Revealed that studies started being published in 2012—a full 7 years before COVID-19—showing Ivermectin’s ability to halt the replication of over 10 RNA viruses, including Dengue, West Nile, Influenza, Zika, and SARS-CoV-1. So, when the World Health Organization (WHO) declared this COVID-19 “pandemic” on March 11, 2020, there was published research that showed the possibility of Ivermectin destroying SARS-CoV-2, which causes COVID-19.
Professor Satoshi Omura, the Nobel Prize-winning co-discoverer of Ivermectin, in his Nobel Prize acceptance speech in 2015, called it “the wonder drug” not only due to its incredible safety as an anti-parasitic in humans but also due to its broad anti-viral and anti-tumor properties. Of course, if Ivermectin can be proven to effectively reduce cancerous tumors, a lot of drug companies would be put out of business.
Professor Omura partnered with Merck to develop Ivermectin into a patented drug to fight parasites and it was given full FDA approval in 1987 to be used in humans. Since that time, Ivermectin has been safely given to hundreds of millions of people all over the globe to fight parasitic infections. According to Dr. Kory, in April of 2020 Professor Omura wrote to Merck for funds to study Ivermectin’s clinical efficacy in COVID.
However, Merck refused to support this Nobel Prize-winner that it formerly partnered with. But Dr. Omura did not stop researching Ivermectin’s efficacy. He and his colleagues published a review paper on Ivermectin in March 2021, which said that, based on the then available 42 controlled trial results, Ivermectin was effective against SARS-CoV-2.
But while Dr. Omura and others were showing the efficacy of Ivermectin, Merck came out to smear its own product, which it had patented in 1987. However, when the patent ran out, which allowed other companies to produce Ivermectin, Merck held a press conference on February 4, 2021, just after the so-called COVID “vaccines” were rolled out, to announce that Ivermectin was not safe or effective.
But at the same time, Merck was making a synthetic product similar to its own Ivermectin that the company could get newly patented to fight COVID and get FDA-approved—and sell it for billions of dollars.
Hospitals were not allowed to give Ivermectin to their patients, but they were told to give their patients the very expensive FDA-approved drug Remdesivir, then put them on oxygen and ventilators—a practice that has now been largely abandoned because of its negative results.
In terms of safety, according to worldwide data from the CDC and FDA, Ivermectin is 61 times safer than Remdesivir and even 68 times safer than Tylenol. Now compare that to the over 33,000 deaths attributed to these COVID “vaccines” since they were rolled out at the beginning of 2021.
Now Drs. Pierre Kory, Paul Marik, Peter McCullough and others are saying that of the over one million or more reported COVID deaths in the U.S., 700,000 could have been saved if their doctors had been allowed to give them the inexpensive, safe, effective, and readily available drugs Ivermectin and hydroxychloroquine (HCQ).
Over the last 2 years the The Final Call newspaper has published exposés, articles, and extensive news briefs in this special section, “COVID 19 and the U.S. Policy of Depopulation.” It suggests that the U.S. government has chosen not to cure the COVID-19 disease, but instead to use it to drive its population to accept untested experimental so-called vaccines produced at “warp speed.”
Information is coming out now that many of the deaths attributed to COVID may have been the result of the introduction of a drug called Midazolam. Midazolam has been used in executions by lethal injection. It can cause serious or life-threatening breathing problems such as shallow, slowed, or temporarily stopped breathing, which may lead to permanent brain injury or death. The Daily Mail of Britain asked a provocative question in a July 11, 2020 headline:
“Did care homes use powerful sedatives to speed Covid deaths? Number of prescriptions for the drug midazolam doubled during height of the pandemic.” They report that prescriptions for the end-of-life drug “doubled at the height of the coronavirus crisis,”
And that in the month of April 2020 prescriptions “increased by more than 100%.” And that this extraordinary rise was “raising fears it was used to control elderly residents in stretched care homes – or even to hasten their deaths.”
Data taken from the Office for National Statistics (ONS) shows us that during April 2020 there were 26,541 deaths in care homes, an increase of 17,850 on the five-year average. This is half the amount of alleged COVID-19 deaths during the same period.
On March 19, 2020, a directive was sent out to the NHS (National Health Service), with Matt Hancock’s authorization, instructing hospitals to discharge all patients who they deemed to not require a hospital bed.” These patients were sent to nursing home facilities.
The Exposé of November 11, 2022 reported that “According to official data in April 2019 up to 21,977 prescriptions for Midazolam were issued….However, in April 2020 45,033 prescriptions for Midazolam were issued….That is a 104.91% increase in the number of prescriptions issued for Midazolam…[and] these [prescriptions] weren’t issued in hospitals; they were issued by GP [General Practitioner] practices which can only mean one thing, they were issued for end-of-life care.
The spikes in production of Midazolam solution match the spikes of alleged COVID deaths within 28 days of a positive test.” This raises a question as to whether the Midazolam could have contributed to deaths, that were designated as COVID Deaths, especially in nursing homes?
That Daily Mail report came just 3 days after the New York Times reported on July 8, 2020, that “The death toll inside New York’s nursing homes is perhaps one of the most tragic facets of the coronavirus pandemic:
More than 6,400 residents have died in the state’s nursing homes and long-term care facilities, representing more than one-tenth of the reported deaths in such facilities across the country….At issue is a directive that [Gov. Andrew] Cuomo’s administration delivered in late March, effectively ordering nursing homes to accept coronavirus patients from hospitals.”
So, it seems that while the United States and England were holding back remedies to fight COVID, like Ivermectin, their actions with respect to the most vulnerable of our senior citizens may have greatly increased death counts, which were then falsely attributed to COVID.
So, as the American and British populations were being scared into receiving gene-altering shots, only 6% of Africa’s 1.4 billion population took those shots. Many leaders of the African countries heeded the warning from Minister Farrakhan on July 4, 2020, to keep those shots out of their countries, and they subsequently experienced many fewer COVID deaths.
Many of these countries were steady users of Ivermectin to fight parasitic diseases, a health practice that has helped the Tribe of Shabazz (Black Africans) escape yet another genocidal death plot by the West.